Southpoint Capital Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-600,000
| Closed | -$111M | – | 44 |
|
|
2024
Q4 | $111M | Sell |
600,000
-69,976
| -10% | -$12.9M | 2.6% | 21 |
|
|
2024
Q3 | $132M | Sell |
669,976
-480,024
| -42% | -$94.6M | 3.13% | 11 |
|
|
2024
Q2 | $238M | Buy |
1,150,000
+450,000
| +64% | +$93M | 5.91% | 3 |
|
|
2024
Q1 | $190M | Sell |
700,000
-300,000
| -30% | -$81.3M | 3.75% | 9 |
|
|
2023
Q4 | $236M | Buy |
1,000,000
+200,000
| +25% | +$47.3M | 5.08% | 4 |
|
|
2023
Q3 | $157M | Buy |
800,000
+400,000
| +100% | +$78.4M | 3.5% | 11 |
|
|
2023
Q2 | $84.1M | Hold |
400,000
| – | – | 1.82% | 22 |
|
|
2023
Q1 | $80.7M | Buy |
+400,000
| New | +$80.7M | 1.83% | 21 |
|
|
2022
Q4 | – | Sell |
-500,000
| Closed | -$98.4M | – | 55 |
|
|
2022
Q3 | $98.4M | Buy |
500,000
+100,000
| +25% | +$19.7M | 2.65% | 15 |
|
|
2022
Q2 | $85.6M | Buy |
+400,000
| New | +$85.6M | 2.43% | 17 |
|